An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
Clinical trial NCT05038878 · TERMINATED
Trial details
- NCT number
- NCT05038878
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-06
- Primary completion
- 2022-06-24
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.